Jonathan Fellers
Addiction Psychiatry · Portland, MENPI 1508091281
Payments from drug & device makers
Across 416 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$1K
- Corium, LLC$738
- Alkermes, Inc.$665
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$610
- Axsome Therapeutics, Inc.$545
- plus $3K from 14 others
What the payments were for
- Food & beverage$7,59999%
- Education$441%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 78 | $1,418 |
| Johnson & Johnson | 55 | $1,050 |
| Corium, LLC | 56 | $738 |
| Alkermes, Inc. | 36 | $665 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 32 | $610 |
| Axsome Therapeutics, Inc. | 31 | $545 |
| Otsuka America Pharmaceutical, Inc. | 21 | $499 |
| Indivior Inc. | 19 | $412 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $302 |
| Teva Pharmaceuticals USA, Inc. | 20 | $253 |
| Braeburn Inc. | 14 | $225 |
| Lundbeck LLC | 8 | $215 |
| Sunovion Pharmaceuticals Inc. | 9 | $209 |
| Ironshore Pharmaceuticals Inc. | 7 | $153 |
| Collegium Pharmaceutical, Inc. | 7 | $144 |
| Jazz Pharmaceuticals Inc. | 4 | $90 |
| E.r. Squibb & Sons, L.L.C. | 2 | $50 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| Noven Therapeutics, LLC | 1 | $18 |
How this compares
Too few addiction psychiatry providers in Maineto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SpravatoEsketamine Hcl | 26 | $34,421 |
| Vilazodone Hcl | 15 | $1,247 |
| Clonazepam | 30 | $927 |
| Gabapentin | 32 | $469 |
| Bupropion XlBupropion Hcl | 11 | $308 |
| Olanzapine | 13 | $188 |
| Clonidine Hcl | 13 | $52 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonSpravato | $1,050 | $34,42126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few addiction psychiatry providers in Maineon file to place this against a meaningful peer group, so we don't.
Other addiction psychiatry in Portland
- Momen El NesrPresque Isle$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.